Cancer statistics, 2025

• DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS <50% NSCLC

  2026 Future Oncology article Medicine Lung Cancer Treatments and Mutations Open access

  0

  citations
• SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [ 68 Ga]Ga-DOTATOC and [ 68 Ga]Ga-SSO120 with [ 18 F]FDG PET

  2026 Journal of Nuclear Medicine article Medicine Radiopharmaceutical Chemistry and Applications

  1

  citations
• The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysis

  2026 European Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access

  0

  citations
• The role of bronchoscopic cryoimmunotherapy in non-small cell lung cancer: current evidence and future perspectives

  2026 Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access

  1

  citations
• Hierarchical Phase-Contrast Tomography Imaging: Applicability in biomedical research

  2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Physics and Astronomy Advanced X-ray Imaging Techniques Open access

  1

  citations
• Short mucin-type O -glycans in cancer: biomarker and therapeutic potential amid analytical barriers

  2025 Glycobiology article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research

  4

  citations

6 results

• Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

  2020 New England Journal of Medicine article Medicine Lung Cancer Diagnosis and Treatment Open access cited by 7 patents

  3,687

  citations

1 result